FDA halts inspections of foreign plants through April due to coronavirus
The ongoing spread of the novel coronavirus has prompted the Food and Drug Administration to postpone most foreign inspections of manufacturing facilities through April.
For the next several weeks, the agency will not conduct routine inspections, but may inspect facilities where manufacturing concerns may exist or perform what is known as a pre-approval inspection, which refers to a facility that is to be used to make a medicine. Such inspections will be considered on a case-by-case basis.
Read Original Article: FDA halts inspections of foreign plants through April due to coronavirus »
